Clinical trial
A Pharmacokinetic Study of Levulan Kerastick (Aminolevulinic Acid HCl) for Topical Solution, 20% Under Maximal Use Conditions
NCT02281136 is registered in ClinicalTrials.gov with DUSA Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pharmacokinetic Study of Levulan Kerastick (Aminolevulinic Acid HCl) for Topical Solution, 20% Under Maximal Use Conditions
- Lead sponsor
- DUSA Pharmaceuticals, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2014
- Completion date
- April 30, 2015
- Enrollment
- 29 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.